User profiles for C. Rowe

Christopher Cleon Rowe

- Verified email at austin.org.au - Cited by 69374

Cathy Rowe

- Verified email at ukhsa.gov.uk - Cited by 2383

[HTML][HTML] NIA-AA research framework: toward a biological definition of Alzheimer's disease

…, T Montine, C Phelps, KP Rankin, CC Rowe… - Alzheimer's & …, 2018 - Elsevier
In 2011, the National Institute on Aging and Alzheimer's Association created separate diagnostic
recommendations for the preclinical, mild cognitive impairment, and dementia stages of …

Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria

…, SE O'Bryant, GD Rabinovici, C Rowe… - Alzheimer's & …, 2016 - Elsevier
During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD)
considering the disease as a continuum. Thanks to evolving biomarker research and …

Alzheimer's disease

…, R Bateman, K Blennow, CC Rowe… - Nature reviews disease …, 2015 - nature.com
Alzheimer's disease is a chronic illness with long preclinical and prodromal phases (20 years)
and an average clinical duration of 8–10 years. The disease has an estimated prevalence …

[BOOK][B] Multiphase flows with

C Crowe, M Sommerfeld, Y Tsuji - 1998 - api.taylorfrancis.com
Since the publication of the first edition of Multiphase Flow with Droplets and Particles in
1998 there have been important advances in the science and technology of dispersed phase …

[HTML][HTML] Epidemiology of Escherichia coli O157: H7 outbreaks, united states, 1982–2002

JM Rangel, PH Sparling, C Crowe… - Emerging infectious …, 2005 - ncbi.nlm.nih.gov
Escherichia coli O157: H7 causes 73,000 illnesses in the United States annually. We reviewed
E. coli O157 outbreaks reported to Centers for Disease Control and Prevention (CDC) to …

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on …

…, TJ Montine, DC Park, EM Reiman, CC Rowe… - Alzheimer's & …, 2011 - Elsevier
The pathophysiological process of Alzheimer’s disease (AD) is thought to begin many years
before the diagnosis of AD dementia. This long “preclinical” phase of AD would provide a …

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

…, F Pasquier, G Rabinovici, P Robert, C Rowe… - The Lancet …, 2014 - thelancet.com
In the past 8 years, both the International Working Group (IWG) and the US National Institute
on Aging–Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's …

[HTML][HTML] SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort …

…, K Potts, M Ramsay, J Robotham, S Rokadiya, C Rowe… - The Lancet, 2021 - thelancet.com
Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to …

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

…, R Martins, P Maruff, D Ames, CC Rowe… - The Lancet …, 2013 - thelancet.com
Background Similar to most chronic diseases, Alzheimer's disease (AD) develops slowly from
a preclinical phase into a fully expressed clinical syndrome. We aimed to use longitudinal …

Statistics for the evaluation and comparison of models

…, DR Legates, J O'donnell, CM Rowe - Journal of …, 1985 - Wiley Online Library
… and c,• is a scalar weight hat corrects Id•l when j is temporally or spatially overrepresentative
… where c can be any value, although the test is often performed with c = 0. With the bootstrap …